SEC Form 4 · accession 0001078782-18-001040
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Sep 10, 2015
Accepted (ET)
Sep 25, 2018 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 20, 2018 | P | 46,689 | $0.17 | A | 20,102,520 | D | |
| Common Stock | Sep 21, 2018 | P | 15,000 | $0.17 | A | 20,117,520 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase WarrantF1 | $0.10 | Sep 10, 2015 | A | 250,000 | A | Sep 10, 2015 | Sep 10, 2020 | Common Stock | 250,000 | 250,000 | D |
| Common Stock Purchase WarrantF1 | $0.10 | Sep 10, 2016 | A | 250,000 | A | Sep 10, 2016 | Sep 10, 2021 | Common Stock | 250,000 | 250,000 | D |
| Common Stock Purchase WarrantF1 | $0.10 | Sep 10, 2017 | A | 500,000 | A | Sep 10, 2017 | Sep 10, 2022 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1A The warrants were issued to the reporting person as compensation for acting as a director.